ATE481406T1 - Pyrrolochinoxalinonderivate als antibakterielle mittel - Google Patents

Pyrrolochinoxalinonderivate als antibakterielle mittel

Info

Publication number
ATE481406T1
ATE481406T1 AT07727528T AT07727528T ATE481406T1 AT E481406 T1 ATE481406 T1 AT E481406T1 AT 07727528 T AT07727528 T AT 07727528T AT 07727528 T AT07727528 T AT 07727528T AT E481406 T1 ATE481406 T1 AT E481406T1
Authority
AT
Austria
Prior art keywords
pyrroloquinoxalinone
derivatives
antibacterial agents
antibacterial
agents
Prior art date
Application number
AT07727528T
Other languages
English (en)
Inventor
Graham Jones
Timothy Miles
Neil Pearson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0606970A external-priority patent/GB0606970D0/en
Priority claimed from GB0706023A external-priority patent/GB0706023D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE481406T1 publication Critical patent/ATE481406T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT07727528T 2006-04-06 2007-03-29 Pyrrolochinoxalinonderivate als antibakterielle mittel ATE481406T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0606970A GB0606970D0 (en) 2006-04-06 2006-04-06 Compounds
GB0706023A GB0706023D0 (en) 2007-03-26 2007-03-26 Compounds
PCT/EP2007/053056 WO2007115947A1 (en) 2006-04-06 2007-03-29 Pyrrolo-quinoxalinone derivatives as antibacterials

Publications (1)

Publication Number Publication Date
ATE481406T1 true ATE481406T1 (de) 2010-10-15

Family

ID=38580721

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07727528T ATE481406T1 (de) 2006-04-06 2007-03-29 Pyrrolochinoxalinonderivate als antibakterielle mittel

Country Status (9)

Country Link
US (1) US7709483B2 (de)
EP (1) EP2001887B1 (de)
JP (1) JP2009532423A (de)
AR (1) AR060287A1 (de)
AT (1) ATE481406T1 (de)
DE (1) DE602007009205D1 (de)
PE (1) PE20080182A1 (de)
TW (1) TW200815450A (de)
WO (1) WO2007115947A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1954697T3 (da) * 2005-10-21 2010-06-14 Glaxo Group Ltd Peri-kondenserede tricykliske forbindelser, der er anvendelige som antibakterielle midler
EP1963324B1 (de) 2005-12-22 2010-04-21 Glaxo Group Limited Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel
GB0608263D0 (en) 2006-04-26 2006-06-07 Glaxo Group Ltd Compounds
GB0613208D0 (en) * 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
AU2008240764C1 (en) * 2007-04-20 2011-10-20 Glaxo Group Limited Tricyclic nitrogen containing compounds as antibacterial agents
BRPI0820394A2 (pt) * 2007-11-26 2015-05-19 Toyama Chemical Co Ltd Composto, método para produzir um composto, derivado do ácido kójico, e, agente antibacteriano.
EP2080761A1 (de) 2008-01-18 2009-07-22 Glaxo Group Limited Verbindungen
MX2010008922A (es) 2008-02-20 2010-09-07 Actelion Pharmaceuticals Ltd Compuestos antibioticos azatriciclicos.
JP5474941B2 (ja) * 2008-05-23 2014-04-16 グラクソ グループ リミテッド 窒素含有三環式化合物およびその抗菌剤としての使用
JP2011520944A (ja) * 2008-05-23 2011-07-21 グラクソ グループ リミテッド 窒素含有三環式化合物および抗菌剤としてのその使用
AR073774A1 (es) 2008-10-07 2010-12-01 Actelion Pharmaceuticals Ltd Compuestos antibioticos oxazolidinona triciclicos
US20110275661A1 (en) 2008-10-17 2011-11-10 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
JP4955835B2 (ja) 2008-12-12 2012-06-20 アクテリオン ファーマシューティカルズ リミテッド ５−アミノ−２−（１−ヒドロキシ−エチル）−テトラヒドロピラン誘導体
US8318940B2 (en) 2009-01-15 2012-11-27 Glaxo Group Limited Naphthyridin-2 (1 H)-one compounds useful as antibacterials
CN101870653B (zh) * 2009-04-23 2013-07-10 上海合全药业有限公司 一种2-甲基-3-氟-6-硝基苯甲酸的合成方法
MX2017002321A (es) 2014-08-22 2017-08-02 Glaxosmithkline Ip Dev Ltd Compuestos que contienen nitrogeno triciclico para tratar infeccion por neisseria gonorrhoeae.
EP3713941B1 (de) 2017-11-24 2022-06-22 Janssen Pharmaceutica NV Pyrazolopyridinonverbindungen

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603199A (en) * 1982-10-25 1986-07-29 Riker Laboratories, Inc. Phenyl-substituted tricyclic antibacterial agent intermediates
JPS6084287A (ja) * 1983-10-14 1985-05-13 Nissan Chem Ind Ltd キノキザリノン誘導体，その製造法および農園芸用殺菌剤
FR2798656B1 (fr) 1999-09-17 2004-12-17 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent
AU2001241332A1 (en) 2000-07-21 2002-02-05 Michail Michailovich Budjonnuj Plate for a stand-up meal
KR20030019621A (ko) 2000-07-26 2003-03-06 스미스클라인비이참피이엘시이 항균 활성을 갖는 아미노피페리딘 퀴놀린 및 그의아자이소스테릭 유사체
FR2816618B1 (fr) 2000-11-15 2002-12-27 Aventis Pharma Sa Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent
GB0031088D0 (en) 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
WO2002050036A1 (en) 2000-12-21 2002-06-27 Ciba Speciality Chemicals Holding Inc. Crystalline forms of cerivastatin sodium
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0118238D0 (en) 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
JP4508650B2 (ja) 2002-01-29 2010-07-21 グラクソ グループ リミテッド アミノピペリジン化合物、当該化合物の製法および当該化合物を含有する医薬組成物
AR038240A1 (es) 2002-01-29 2005-01-05 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para su preparacion
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
AR040336A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
GB0217294D0 (en) 2002-07-25 2002-09-04 Glaxo Group Ltd Medicaments
FR2844268B1 (fr) 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
FR2844270B1 (fr) 2002-09-11 2006-05-19 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
US7223776B2 (en) 2002-10-10 2007-05-29 Morphochem Ag Compounds with anti-bacterial activity
JP4704755B2 (ja) 2002-11-05 2011-06-22 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 抗菌剤
ATE479683T1 (de) 2002-11-05 2010-09-15 Glaxo Group Ltd Antibakterielle mittel
AR042486A1 (es) 2002-12-18 2005-06-22 Glaxo Group Ltd Compuesto de quinolina y naftiridina halosustituido en la posicion 3, procedimiento para preparar el compuesto, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion .
TW200507841A (en) 2003-03-27 2005-03-01 Glaxo Group Ltd Antibacterial agents
FR2852954B1 (fr) 2003-03-28 2006-07-14 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
DE10316081A1 (de) 2003-04-08 2004-10-21 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
WO2004104000A1 (ja) 2003-05-23 2004-12-02 Japan Tobacco Inc. トリサイクリック縮合環化合物およびその医薬用途
FR2858619B1 (fr) 2003-08-08 2006-12-22 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
FR2867472B1 (fr) 2004-03-12 2008-07-18 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
US7691850B2 (en) 2004-06-15 2010-04-06 Glaxo Group Limited Antibacterial agents
FR2872164B1 (fr) 2004-06-29 2006-11-17 Aventis Pharma Sa Derives de quinoleines-4-substituees, leur procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
EP1773831A1 (de) * 2004-07-08 2007-04-18 Glaxo Group Limited Antibakterielle mittel
JP2008505926A (ja) 2004-07-09 2008-02-28 グラクソ　グループ　リミテッド 抗細菌剤
JP2008506695A (ja) 2004-07-13 2008-03-06 グラクソ　グループ　リミテッド 抗細菌剤
JP2008507543A (ja) 2004-07-22 2008-03-13 グラクソ　グループ　リミテッド 抗細菌剤
JP2008508359A (ja) 2004-08-02 2008-03-21 グラクソ グループ リミテッド 抗菌剤
US20070161627A1 (en) 2004-08-09 2007-07-12 Miller William H Antibacterial agents
DE102004041163A1 (de) 2004-08-25 2006-03-02 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
CA2580621A1 (en) 2004-09-24 2006-03-30 Actelion Pharmaceuticals Ltd New bicyclic antibiotics
ES2343127T3 (es) 2004-10-05 2010-07-23 Actelion Pharmaceuticals Ltd. Nuevos antibioticos de piperidina.
JP5314244B2 (ja) 2004-10-27 2013-10-16 富山化学工業株式会社 新規な含窒素複素環化合物およびその塩
EP1846411A4 (de) 2005-01-25 2010-08-04 Glaxo Group Ltd Antibakterielle wirkstoffe
US7709472B2 (en) 2005-01-25 2010-05-04 Glaxo Group Limited Antibacterial agents
EP1846416A4 (de) 2005-01-25 2009-07-01 Glaxo Group Ltd Antibakterielle wirkstoffe
EP1846418A4 (de) 2005-01-25 2009-12-23 Glaxo Group Ltd Antibakterielle wirkstoffe
WO2006081264A1 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
WO2006099884A1 (en) 2005-03-24 2006-09-28 Actelion Percurex Ag Beta-aminoalcohol antibiotics
AU2006230364B2 (en) 2005-03-31 2012-09-13 Janssen Pharmaceutica N.V. Bicyclic pyrazole compounds as antibacterial agents
US20090131444A1 (en) 2005-05-24 2009-05-21 Astrazeneca Ab Aminopiperidine Quinolines and Their Azaisosteric Analogues with Antibacterial Activity
US7981886B2 (en) 2005-05-25 2011-07-19 Actelion Pharmaceutical Ltd. Antibiotics derivatives
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
EP2468743A1 (de) 2005-06-24 2012-06-27 Toyama Chemical Co., Ltd. Bicyclischen Stickstoff enthaltende heterocyclische Verbindungen zur Verwendung als antibakterielle Mittel
DK1954697T3 (da) 2005-10-21 2010-06-14 Glaxo Group Ltd Peri-kondenserede tricykliske forbindelser, der er anvendelige som antibakterielle midler
EP1963324B1 (de) 2005-12-22 2010-04-21 Glaxo Group Limited Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel
GB0608263D0 (en) 2006-04-26 2006-06-07 Glaxo Group Ltd Compounds
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
GB0705672D0 (en) 2007-03-23 2007-05-02 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
TW200815450A (en) 2008-04-01
AR060287A1 (es) 2008-06-04
EP2001887A1 (de) 2008-12-17
US7709483B2 (en) 2010-05-04
PE20080182A1 (es) 2008-05-01
EP2001887B1 (de) 2010-09-15
DE602007009205D1 (de) 2010-10-28
US20090062265A1 (en) 2009-03-05
WO2007115947A1 (en) 2007-10-18
JP2009532423A (ja) 2009-09-10

Similar Documents

Publication Publication Date Title
ATE481406T1 (de) Pyrrolochinoxalinonderivate als antibakterielle mittel
ATE460417T1 (de) Acetylenylpyrazolopyrimidinderivate als mglur2- antagonsten
DK1912647T3 (da) Quinolinderivater som antibakterielle midler
DK2054030T3 (da) Antimikrobielle midler
BRPI0720220A2 (pt) Derivados de quinolinas antibacterianos
DK1901743T3 (da) Quinolinderivater som antibakterielle midler
ATE443753T1 (de) Nuancierungsmittel
DK1912648T3 (da) Quinolinderivater som antibakterielle midler
DK2034997T3 (da) Antibakterielle sammensætninger
ATE475662T1 (de) Dihydropyrazolopyrimidinonderivate
ATE483711T1 (de) Spiroindolinonderivate
ATE469905T1 (de) Pyridopyrimidinonderivate
ATE512135T1 (de) Spiroindolinonderivate
DK2035394T3 (da) 2-pyrazincarboxamidderivater
DE602006010508D1 (de) Substituierte triazolderivate als oxytocinantagonisten
ATE451356T1 (de) Substituierte arylsulfonamide als antivirale mittel
DK2086968T3 (da) 5-hydroxymethyl-oxazolidin-2-on-derivater
DE602007006553D1 (de) Antibakterielle chinolinderivate
DK1912649T3 (da) Quinolinderivater som antibakterielle midler
DK2099759T3 (da) Antibakterielle chinolinderivater
DK1898914T3 (da) Quinolinderivater som antibakterielle midler
DK2099760T3 (da) Antibakterielle quinolinderivater
DE602007006231D1 (de) Antibakterielle chinolinderivate
BRPI0712951A2 (pt) Unidade de aplicação
DE602007010182D1 (de) Antibakterielle chinolinderivate

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties